Read the study on the publisher's site.
We show that respiratory fluoroquinolone use is extremely seasonal and that fluoroquinolone use is strongly associated with influenza. In our time series model, instantaneous influenza activity was a significant predictor of use ([Formula: see text]). Also, we estimated that reducing influenza activity by 20% would reduce prescriptions by 8%.
Philip M. Polgreen
J. E. Cavanaugh
|Keywords||antibiotic resistance, Technical Papers|